EPSTI1 as an immune biomarker predicts the prognosis of patients with stage III colon cancer

ObjectiveThe poor prognosis and heterogeneity of stage III colon cancer (CC) suggest the need for more prognostic biomarkers. The tumor microenvironment (TME) plays a crucial role in tumor progression. We aimed to explore novel immune infiltration-associated molecules that serve as potential prognos...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Xitao Wang, Wei Cheng, Xingzhi Zeng, Xiaolin Dou, Zhongyi Zhou, Qian Pei
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Subjects:	colon cancer immune infiltration single-cell sequencing EPSTI1 prognostic marker
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.987394/full